MILESTONE (MMD): Milestone Medical Inc to Present at 2nd Global Life Sciences Conference in Warsaw, Poland - raport 23

Milestone Medical Inc. to Present at 2nd Global Life Sciences Conference in Warsaw


The Board of Directors of Milestone Medical Inc. (WAR: MMD, the “Company”, “Issuer”), today announced that Leonard Osser, Chief Executive Officer of the Company will present at the upcoming 2nd Global Life Sciences Conference in Warsaw on October 2, 2014 at the trading floor of the Warsaw Stock Exchange, Warsaw, Poland. A recording of the presentation will be posted on the Issuer’s website following the conference.


Warsaw, the financial capital of Central and Eastern Europe, is a major center of life science investment. On October 2nd, at the Global Life Sciences Conference, over 100 leading life science institutional investors, fund managers and analysts from Central and Eastern Europe will gather in Warsaw to discuss and assess new investment opportunities. They will have access there to the Company’s management through a corporate presentation and small group meetings.

Reklama

The organizers of this event are: WDM Capital, Wedbush Europe and the Filipex Enterprises. The partners of this event are: Warsaw Stock Exchange, Wedbush, Wierzbowski Eversheds and Crescendo Communications. For more information please visit: http://lscwarsaw.com


Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market



Osoby reprezentujące spółkę:
Leonard Osser - CEO
Joseph D'Agostino - CFO

GPW
Dowiedz się więcej na temat: war | voice | I.N.C.
Reklama
Reklama
Reklama
Reklama
Strona główna INTERIA.PL
Polecamy
Finanse / Giełda / Podatki
Bądź na bieżąco!
Odblokuj reklamy i zyskaj nieograniczony dostęp do wszystkich treści w naszym serwisie.
Dzięki wyświetlanym reklamom korzystasz z naszego serwisu całkowicie bezpłatnie, a my możemy spełniać Twoje oczekiwania rozwijając się i poprawiając jakość naszych usług.
Odblokuj biznes.interia.pl lub zobacz instrukcję »
Nie, dziękuję. Wchodzę na Interię »